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Abstract
Vascular endothelial growth factor (VEGF) plays a critical role in normal development as well as retinal vasculature disease.
During retinal vascularization, VEGF is most strongly expressed by not yet vascularized retinal astrocytes, but also by retinal
astrocytes within the developing vascular plexus, suggesting a role for retinal astrocyte-derived VEGF in angiogenesis and
vessel network maturation. To test the role of astrocyte-derived VEGF, we used Cre-lox technology in mice to delete VEGF in
retinal astrocytes during development. Surprisingly, this only had a minor impact on retinal vasculature development, with
only small decreases in plexus spreading, endothelial cell proliferation and survival observed. In contrast, astrocyte VEGF
deletion had more pronounced effects on hyperoxia-induced vaso-obliteration and led to the regression of smooth muscle
cell-coated radial arteries and veins, which are usually resistant to the vessel-collapsing effects of hyperoxia. These results
suggest that VEGF production from retinal astrocytes is relatively dispensable during development, but performs vessel
stabilizing functions in the retinal vasculature and might be relevant for retinopathy of prematurity in humans.
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Introduction
Retinal astrocytes play an important role in the development of
the mammalian retinal vasculature. They invade the retina from
the optic nerve head as a proliferating population of cells and
spread across the inner surface of the retina, creating a template
for the developing retinal vasculature which follows in their wake
[1–4]. There is a tight correlation between the presence of retinal
astrocytes and the retinal vasculature. In animals with only
partially vascularized retinas, such as rabbit and horse, retinal
astrocytes are absent from the avascular regions of the retina [5,6].
Furthermore, in primates, retinal astrocytes are absent from the
foveal avascular zone [7,8].
Numerous studies have shown that during retinal vascularization
retinal astrocytes produce high levels of Vegf mRNA in the not yet
vascularized peripheral portion of the retina [9–11]. This part of the
retina is experiencing physiological hypoxia during development
[9], increasing VEGF transcription possibly via hypoxia inducible
factors (HIFs) or Vegf mRNA stabilization [12,13]. This differential
expression of VEGF - high in the periphery and low in the centre -
might lead to a gradient providing a directional stimulus for retinal
vascularization. Furthermore, the development of the retinal
vasculature can be accelerated and delayed by intra ocular injection
of inhibitors or activators of VEGF signalling [14]. VEGF is
therefore considered a likely mediator of astrocyte-vessel interac-
tions during the outgrowth of the retinal vasculature.
Apart from driving angiogenesis, VEGF may also influence
vessel remodelling, stabilization and differentiation during
vascular plexus maturation. The stability of vessels plays an
important role in the pathogenesis of retinopathy of prematurity
(ROP), where exposure of premature infants to therapeutic
hyperoxia can cause vaso-obliteration in the developing retinal
vasculature [15]. Many in vitro studies have demonstrated that
VEGF can act as a mitogen and as a survival factor for
endothelial cells [16–19]. Evidence from in vivo models further
supports this. For instance, it is likely that the strong vaso-
obliterative effects of hyperoxia in the retina are at least in parts
mediated via the suppression of VEGF expression. Exposing
mouse pups to a 75% oxygen atmosphere from postnatal day 7
(P7) to P12 obliterates capillaries in the centre of the retina [20].
This correlates with a reduction of VEGF expression in the same
retinal region and can be prevented by intra vitreal injection of
VEGF [1,21]. Furthermore, high oxygen levels in arterial blood
are likely to be responsible for suppression of Vegf mRNA near
arteries and consequently for the formation of so-called capillary
free spaces along arteries [22]. These capillary free spaces widen
when mice are exposed to hyperoxia and disappear when the
pups are raised under hypoxic conditions. These changes
correlate with decreased and increased VEGF expression
respectively [21,23], further supporting the notion that VEGF
expression within the vascular plexus influences vessel survival
and consequently network topology.
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It has been shown that VEGF secreted from pericytes can also
contribute to vessel stabilization [24], and vessels lacking mature
pericytes are prone to regression in the hyperoxia model [25].
Stabilization of blood vessels is based on a endothelial cell-pericyte
interactions [26], which clearly plays an important role in the
remodelling and shaping of the retinal vasculature. This is further
illustrated by the fact that hyperoxia exposure spares the larger,
more mature arteries and veins that are radially projecting from
the centre to the periphery. Also, in more mature animals (about 3
weeks old) the retinal vasculature is no longer sensitive to
hyperoxia-induced vaso-obliteration [27].
However, it is less clear to which degree retinal astrocytes and
pericytes contribute to vessel stabilization and how important
VEGF secretion from these cells is during the critical period of
network maturation in the first 2–3 weeks after birth. We
therefore investigated the role of astrocyte-derived VEGF in
retinal vascular development by genetically abolishing VEGF
expression using the Cre-lox system. Surprisingly, this only had a
minor impact on the physiological development of the retinal
vasculature. However, under hyperoxic conditions deletion of
astrocyte-derived VEGF led to a pronounced destabilization of
the retinal vasculature.
Results
Retinal astrocyte-derived VEGF is not required for retinal
vascularization
In the developing retina Vegf mRNA is expressed by retinal
astrocytes, retinal ganglion cells and cells in the inner nuclear layer
(Fig. 1A) [7,28–30]. Retinal astrocytes display the strongest Vegf
mRNA expression, with particularly high levels distally to the
growing vascular plexus, where the tissue is still avascular and
hypoxic (Fig. 1B). To test the role of retinal astrocyte-derived
VEGF, we employed the Cre-lox system. Astrocytes were targeted
using a mouse strain that expresses Cre recombinase under the
control of the glial fibrillary acidic protein (Gfap) promoter (Gfap-
Cre mice) [31]. Retinal astrocytes-specific Cre recombination
activity was confirmed in the ROSA-lacZ reporter strain [32],
which demonstrated lacZ expression in retinal astrocytes within
the vascular plexus but also in astrocytes in the peripheral, not yet
vascularized portion of the retina (Fig. 1C).
Retinal astrocyte deletion of VEGF was achieved by breeding
the Gfap-Cre allele into a homozygous background containing loxP
sites flanking exon 3 of the Vegfa gene (Vegf c/c mice) [33]. Offspring
containing the Gfap-Cre allele was compared against littermates
without the transgene. Cre recombinase activity in Gfap-Cre
positive animals was confirmed by PCR of genomic DNA isolated
from the retina with primers spanning a 2.1kb region across exon
3, which demonstrated deletion of a 1.3kb region in the Vegfa gene
with the appearance of an additional shorter band of 800bp in
Cre-positive animals (Fig. 1D, E). The larger 2.1kb band remains
in transgenic animals because VEGF is not only expressed in
retinal astrocytes but also in other retinal cells, such as neurons
and Mu¨ller cells, which are not affected by Gfap-Cre strain-
mediated excision.
It is possible that different cells in the retina express different
VEGF isoforms [34,35]. We therefore tested whether astrocyte
VEGF deletion can change the VEGF isoform ratios. RT-PCR on
mRNA isolated from P5 retinas revealed that VEGF164 was the
dominant isoform in the retina, whereas VEGF120 was expressed
at lower levels and VEGF188 was barely detectable. Importantly,
this was found in both wild type and astrocyte VEGF knock-out
animals (Fig. 1F), demonstrating that VEGF isoforms ratios are
not changed.
In order to assess the effects of astrocyte deletion of VEGF in
the retina, we studied the retinal vasculature at P5. Surprisingly,
development of the retinal vasculature was almost normal apart
from subtle abnormalities. In Cre-positive mutant mice, the
vascular network seemed slightly irregular and less developed than
in their wild type counter parts (Fig. 1G, H). Since hypoxia can
regulate VEGF transcription via hypoxia-inducible factor 1 alpha
(HIF1a) we also studied animals with astrocyte deletion of HIF1a.
To this end, the Gfap-Cre strain was crossed into a background
containing homozygous floxed Hif1a alleles [36]. This did not lead
to the same abnormalities observed following VEGF deletion, and
had no apparent effect on the retinal vasculature whatsoever
(Fig. 1I, J), demonstrating that HIF1a does not contribute
significantly to the regulation of VEGF in the retinal astrocytes.
The lack of any noticeable phenotype after HIF1a deletion also
served as a negative control against possible non-specific effects of
the Gfap-Cre transgene.
Delayed angiogenesis
The pronounced expression of VEGF in peripheral astrocytes
(in the not yet vascularized part of the retina) has been linked to
sprouting angiogenesis at the leading edge of the expanding
vascular plexus. We therefore assessed whether the absence of
VEGF in astrocytes affected the morphology of angiogenic sprouts
at the leading edged of the growing vascular plexus, but found no
noticeable differences (Fig. 2A, B). To further investigate effects on
vascular sprouting, the surface area covered by the retinal
vasculature was measured (Fig. 2C). Quantification of 6 separate
litters at P5 revealed that average spreading of the vessel network
in the mutant animals was reduced by 24% (p= 0.004) (Fig. 2D).
This represents a subtle, but significant, delay of angiogenesis.
However, at P10, this difference was reduced to 10%, and was no
longer statistically significant (p = 0.053). These findings suggest
that the observed retinal vasculature impairment was transient and
that the delay in angiogenesis was eventually overcome (Fig. 2D).
No delay was observed after astrocyte HIF1a deletion (Fig. 2D),
confirming the lack of phenotype shown above (Fig. 1I, J).
Effect of astrocyte-derived VEGF on endothelial cell
proliferation and survival
Although vascularization causes retinal astrocytes to downregu-
late Vegf mRNA, the in situ hybridization signal was still detectable
within the vascular plexus, particularly along veins (Fig. 1B). It is
possible that this VEGF expression influences the proliferation and
survival of endothelial cells as the vascular network undergoes
remodelling and maturation. For instance, the relatively high levels
of Vegf mRNA near veins correlate with high proliferation rates in
developing veins (Fig. 2E). To assess a possible effect of astrocyte-
derived VEGF, we quantified the number of BrdU-positive nuclei in
veins in P10 animals. At this age, the vascular plexus undergoes
extensive remodelling, and proliferation rates were noted between
veins and arteries. In our VEGF-deleted animals, the number of
labelled cells was reduced by 20% (p= 0.027) compared to control
animals, again suggesting a small but significant influence of
astrocyte-derived VEGF (Fig. 2F).
In order to establish whether astrocyte-derived VEGF can also
influence endothelial cell survival in the developing retinal
vasculature, we analyzed network morphology around arteries.
VEGF expression is naturally very low in these regions and
abolishing astrocyte-derived VEGF is therefore likely to have the
biggest impact on endothelial cell survival near arteries. We
measured the width of capillary free spaces around arteries, but
found no difference between VEGF-deleted and control animals
(Fig. 2G, H). We then counted the number of primary artery side
Retinal Vessel Stabilization
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branches, and found a reduction at P5 (24%, p= 0.011) and at P10
(11%, p= 0.014), demonstrating that astrocyte-derived VEGF
contributes to endothelial cell survival within the capillary-free
zones around arteries (Fig. 2 G, H).
Astrocyte-derived VEGF protects vessels from oxygen-
induced obliteration
Since astrocyte-derived VEGF increases endothelial cell survival
in the relatively high oxygen environment near arteries, we
decided to test whether this is also true under more extreme
circumstances. To this end, P7 pups were exposed to 75% oxygen
for 5 days, which obliterates capillaries around arteries and in the
centre of the retina. In animals lacking astrocyte-derived VEGF,
the area where capillaries were obliterated was dramatically
increased (65%, p= 0.003, Fig. 3A–C). Furthermore, the usually
stable main arteries and veins showed an increased tendency to
collapse causing a reduction of vessels extending from the optic
nerve (49%, p= 0.004, Fig. 3A–C). In some instances this led to
isolated, non-perfused patches of capillaries in the periphery
(arrowhead Fig. 3B). Since VEGF levels are not suppressed by the
75% oxygen atmosphere in this region of the retina [21], vessels
survive. However, they hyperproliferate and normal network
Figure 1. Astrocyte specific deletion of VEGF. (A, B) In situ hybridisation showed Vegf mRNA expression in a retinal cross-section (A) and a
retinal whole mount (B) at P5. (A) Vegf mRNA was most strongly expressed in retinal astrocytes (arrowhead), and weakly in retinal ganglion cells and
the inner nuclear layer (arrows). (B) Retinal astrocytes expressed VEGF strongest distally to the edge of growing vascular plexus (white arrowheads), at
intermediate levels around veins (v) and weakest along arteries (a). (C) Transgenic mice expressing Cre recombinase in retinal astrocytes (Gfap-Cre
mice) showed in a lacZ reporter strain recombination activity (black X-gal stain in C) in retinal astrocytes proximally and distally to the growing edge
of the vascular plexus (arrowheads in C). (D, E) Cre recombination in Vegfc/c mice, crossed with Gfap-Cre mice, was demonstrated by PCR across the
deleted region in genomic DNA from retinas in Cre positive (mt) and Cre negative (wt) animals (D). PCR on tail DNA identified Cre negative and
positive animals (E). (F) PCR on cDNA from retinal mRNA showed unchanged VEGF isoform ratios in control and mutant animals. Astrocyte deletion of
VEGF led to subtle abnormalities in the P5 retinal vasculature (stained with an anti-claudin 5 antibody G–J) in Cre positive animals (H) compared to
wild type litter mates (G). In contrast, deletion of HIF1a in retinal astrocytes caused no such abnormalities (I–J). Scale bars are 100mm in A, 200mm in B,
C and 1000mm in G.
doi:10.1371/journal.pone.0011863.g001
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morphology is lost, demonstrating important stabilizing effects of
vascular perfusion on vascular network development.
It has been reported that hyperoxia can induce retinal astrocyte
death [37–39]. To determine whether astrocyte cell death
contributes to the effects observed in our mutant animals, we
visualized retinal astrocytes at P12 (using an anti-GFAP antibody).
The astrocytes had similar morphologies and densities in control
and mutant animals (Fig. 3D, E). Quantification of cell numbers
also revealed no differences (not shown). Interestingly, while
mouse retinal astrocytes normally show a strong spatial interaction
with blood vessels, following hyperoxia-induced vessel-oblitera-
tion, retinal astrocytes re-aligned themselves radially with what
appear to be axon fibre bundles (arrowheads Fig. 3D, E).
In order to gain more insight into the process of vessels-
obliteration, we also studied animals after 24 hours of hyperoxia
exposure at P8. Vegf mRNA was suppressed most strongly around
arteries, but still detectable throughout the network (Fig. 4A–C).
Immunohistochemistry with antibodies against collagen IV and
claudin 5 (labelling basement membranes and endothelial cell
junctions respectively, Fig. 4D–F) was used to visualize capillaries
at different stages of obliteration. In some instances, only thin
basement membrane sleeves, devoid of endothelial cells, could be
observed (arrowheads Fig. 4D). Other vessels contained claudin 5
positive clumps (most likely dying endothelial cells) and were
isolated from the rest of the network (arrows Fig. 4D). The earliest
abnormality displayed by radial veins and arteries were local
reductions in vessel diameter with seemingly still intact endothelial
junctions (Fig. 4E, F). Active caspase-3-positive reactivity was
found inside vessels with degenerating morphology, but not in
vessels with normal appearance (Fig. 4G, H), indicating that
endothelial cells undergo apoptosis within collapsing blood vessels.
In wild type animals, we found typically one degenerating vein per
retina and only one degenerating artery every five retinas (Fig. 4I).
In animals that lacked astrocyte-derived VEGF, this ratio between
veins and arteries roughly persisted (6:1, p= 0.001) but the overall
frequency of visibly degenerating vessels more than doubled. This
was particularly obvious with veins, which degenerated 2.4 times
more often (p = 0.019) in mutant animals (Fig. 4I). These results
suggest that at this stage of retinal vascular development veins are
more vulnerable to hyperoxia and that astrocyte-derived VEGF
has a stabilizing and protecting influence on them.
Discussion
Our experiments have demonstrated that the role retinal
astrocytes play in retinal vascularization is mediated only in a
small part by VEGF. The most likely explanation for the minor
effects of astrocyte VEGF deletion on retinal angiogenesis is
compensation of VEGF production by other cells, such as
neurons. In comparison to retinal astrocytes, RGCs and cells in
the inner nuclear layer display a much weaker in situ hybridization
signal for Vegf mRNA, but because these low expressing cells are
more abundant, VEGF is likely to be produced in sufficient
quantities to allow for almost normal vascularization. It is likely
that there are other aspects of retinal astrocytes that involve these
cells critically in retinal vascularization. For instance, it has been
suggested that retinal astrocytes mediate extracellular assembly of
fibronectin matrices required for vessel growth [40]. It is also
possible that they provide not yet identified factors that are
required for retinal angiogenesis.
Nevertheless, retinal vascularization was not entirely unaffected
after astrocyte VEGF deletion. Speed of angiogenesis, endothelial
cell proliferation and survival were all subtly but reproducibly
reduced. Every one of these features suggests that there is reduced
VEGF activity in the retina during development, which is
consistent with our experimental design that targeted only a
subpopulation of cells in the retina. Interestingly, deletion of
HIF1a had no effect on the development of the retinal vasculature,
suggesting that in retinal astrocytes, the primary regulation of
VEGF expression is HIF1a-independent. In concordance with
that, in mice lacking the hypoxia response element in the VEGF
promoter the retinal vasculature develops normally [41]. Alterna-
tively, VEGF might also be regulated via the stabilization of its
mRNA under hypoxic conditions [12]. In fact, it has been shown
Figure 2. Effects of astrocyte-derived VEGF on retinal vascular
development. Immunohistochemistry, visualizing endothelial cells
(claudin 5, green in A, B, C, E, G) and retinal astrocytes (GFAP, red in A,
B), shows that angiogenic sprouting at the leading edge of the growing
vascular plexus appears normal in control (A) and mutant (B) animals
lacking astrocyte derived VEGF. (C, D) Measurement of the surface area
of the retinal vasculature (C) showed significantly reduced spreading in
Vegfc/c mutants at P5 but not at P10 and not in P5 Hif1ac/c mutants at
P5. (E) AT P10 proliferation (anti-BrdU in red) occurs predominantly in
veins and is reduced in animals lacking astrocyte-derived VEGF in
comparison to littermate controls. (G–H) Endothelial cell survival near
arteries was assessed by measuring the width of the capillary free zone
(CFS, white arrows) and the number of artery side branches (black
arrowheads). (H) In mutant animals CFS width was not affected but the
number of side branches was reduced. Scale bars are 50mm in A,
1000mm in C and 200mm in G; * is p,0.05 and ** is p,0.01.
doi:10.1371/journal.pone.0011863.g002
Retinal Vessel Stabilization
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that regulation of VEGF production via this mechanism is more
potent in comparison to transcriptional control [42].
Compared to the relatively subtle effects on the speed of retinal
angiogenesis and endothelial cell proliferation, astrocyte VEGF
deletion had more pronounced consequences on vessel stability.
Although, the width of capillary free spaces was unchanged, the
number of artery side branches was clearly reduced. It therefore
appears that during normal development astrocyte-derived VEGF
is only critical for endothelial cell survival within a defined zone
around arteries, where high oxygen and low VEGF levels prevail.
However, when animals were exposed to hyperoxia, this zone
dramatically expanded, and animals that lacked astrocyte-derived
VEGF were more affected. Most noticeably, radial arteries and
veins became more susceptible to collapse in mutant animals. These
large vessels have been considered to be resistant to hyperoxia due
to their maturity and, in the case of arteries, due to their association
with vascular smooth muscle cells [25]. However, our results
demonstrate that reducing the supply of VEGF can still affect these
vessels within the first postnatal week of retinal vasculature
development. Why in this instance other sources of VEGF in the
retina do not rescue the dying vessels is not clear. Although we
found no changes in VEGF isoform ratios in our mutant mice, it is
likely that an additional layer of complexity is added by mechanisms
that control distribution and bioavailability of VEGF protein. Since
our study focuses only on Vegf mRNA production and distribution
we cannot exclude that the distribution of astrocyte-derived VEGF
protein might be different from neuron-derived VEGF protein.
In pupillary membrane vessels, which naturally regress during
development, it has been shown that blocking VEGF function
accelerates regression [19]. Macrophages can mediate local
endothelial cells death [43] and cause the cessation of blood flow,
which then leads to the appearance of synchronous apoptosis
throughout the entire vessel [19,44]. In our system, we observed a
similar phenomenon, where radial vessels displayed dying cells
throughout their entire length and degenerated synchronously
within 24 hours of hyperoxia exposure. This is most likely
mediated through blood flow interruptions caused by local
narrowing of vessel lumens. The higher vulnerability of veins in
comparison to arteries could be explained by the lower numbers of
smooth muscle cells and pericytes coating the vessels, as it is likely
that the transition to VEGF-independence is based on a maturing
relationship between endothelial cells and pericytes [26]. Further-
more, VegfmRNA levels were lower along arteries than along veins
during hyperoxia exposure (Fig. 4A–C). This explains the relative
insensitivity of VEGF deletion in arteries compared to veins.
Vessel destabilization and obliteration are critical processes in
the pathogenesis of ROP where supplemental oxygen therapy and
lack of growth factors causes vessel loss [45]. IGFBP3 and Epo
have both been shown to support endothelial cell survival and
mouse strains lacking these factors displayed increased hyperoxia-
induced vessel loss [46,47]. However, to what degree the signalling
of these vessel-protective factors involves retinal astrocytes is not
well understood and so far they have not found application in the
clinic. On the other hand, anti-VEGF therapy has now been
applied in ROP cases [48], with the intention to prevent vascular
proliferation. Although it is likely that these approaches do not
result in a complete deletion of VEGF activity in the retina, our
study highlights the important vessel stabilizing function of VEGF
in the immature retinal vasculature.
Materials and Methods
Mice
All animals were handled in accordance with the UK Animals
(Scientific Procedures) Act 1986. The project was approved by the
UK Home Office and the UCL Institute of Ophthalmology Ethics
Sub-Committee (approval ID PPL 70/6305). Transgenic mice
expressing Cre recombinase under the control of promoter
Figure 3. Astrocyte-derived VEGF protects vessels from hyperoxia. After hyperoxia exposure from P7–12 immunohistochemistry was used
to visualize vessels with isolectin B4 (green, A, B), collagen IV (green, D, E) and retinal astrocytes (GFAP, red, D, E). (A–C) Deletion of astrocyte specific
VEGF increased the vaso-obliterated area and led to decreased survival of radial arteries and veins. In some instances this lead to non-perfused,
hyperproliferating capillary beds in the periphery (arrowhead in B). (D, E) Retinal astrocyte survival was not affected at this age but in areas of capillary
loss astrocytes re-aligned with nerve bundles (arrowheads D, E). Scale bars are 100mm in A and 100mm in D; ** is p,0.01.
doi:10.1371/journal.pone.0011863.g003
Retinal Vessel Stabilization
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segment from the human GFAP gene [31] were crossed into
homozygous backgrounds of conditional VEGF (Vegf c/c) [33] and
conditional HIF1a (Hif1ac/c) [36]. Analysis was performed on
litters containing animals with the Cre transgene and control
littermates without it. Litters were exposed with their feeding
mothers to hyperoxia (75% Oxygen) as described previously [23].
PCR
To confirm Cre recombinase activity genomic DNA was
isolated from P5 retinas and amplified by PCR using Megamix
(Cambio Ltd.) containing 2% DMSO with the following primers:
forward CAG GCT TCG GTG GGG TGT GA and reverse
GAG CAG GGA TAG GTG GTG GAG ATA. To assess VEGF
isoforms reverse-transcribed cDNA obtained from P5 retinas was
amplified using Taq polymerase (Promega). The VEGF isoform
primer sequences were: forward GAA GTC CCA TGA AGT
GAT CCA G and reverse TCA CCG CCT TGG CTT GTC A,
as described previously [49]. The primers which were located on
exon 3 (forward) and exon 8 (reverse), can amplify all the isoforms
of murine VEGF. Different isoforms were identified in a 2.5%
agarose gel according to the molecular weight of PCR products.
Histology
Retinal whole mount preparations were dissected from whole
eyes after brief fixation in 2% (w/v) paraformaldehyde (PFA) in
phosphate-buffered salt solution (PBS) and then processed for
wholemount immunohistochemistry or in situ hybridization as
previously described [9]. In some instances, fluorescent anti
collagen IV immunostaining was carried out following in situ
hybridization to visualize blood vessels. Proliferation was visual-
ized in whole mount preparations that have been stained to
visualize vessels with subsequent fixation and HCl treatment prior
to anti-BrdU immunohistochemistry, as previously described [9].
For X-gal staining tissue was dissected, fixed in 0.2% glutaralde-
hyde and processed as previously described [50]. Antibodies used
were rabbit anti-Claudin 5 (Invitrogen), rabbit anti-collagen type
IV (AbD Serotec), goat anti-collagen type IV (GeneTex), FITC-
conjugated isolectin B4 (Vectorlabs), Cy3-conjugated mouse anti-
GFAP (Sigma), mouse anti-BrdU [51], rabbit anti-active caspase 3
(Abcam) and secondary Alexa-488 and Alexa-546 antibodies
(Molecular Probes).
Vascular network analysis
Network morphology of the retinal vasculature was analyzed in
retinal whole mount preparations from 6 P5 and 5 P10 conditional
VEGF litters and in 5 P5 conditional HIF1a litters. We also
analyzed 5 further litters after hyperoxia exposure for 5 days at
P12 and 5 litters after 1 day of hyperoxia at P8. The surface area
of the developing vascular network, width of capillary free spaces
and vascular depleted areas in hyperoxia-exposed animals were
measured using ImageJ. BrdU positive cells and artery side
branches were counted by hand over fixed distances from the
retinal centre. Intact and degenerating radial arteries and veins
were counted by hand in each retina. Measurements were
averaged for control and mutant animals in each litter and
normalized against the control values. Statistical analysis was then
performed across values obtained from each litter.
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